OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study
Troy J. Kemp, Heidi Hempel, Yuanji Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 12
Troy J. Kemp, Heidi Hempel, Yuanji Pan, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 12
Showing 12 citing articles:
The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays
Heidi Hempel, Mark Page, Troy J. Kemp, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e301-e305
Open Access | Times Cited: 8
Heidi Hempel, Mark Page, Troy J. Kemp, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e301-e305
Open Access | Times Cited: 8
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
Jimmie Bullock, Thomas E. Hickey, Troy J. Kemp, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 516-516
Open Access | Times Cited: 5
Jimmie Bullock, Thomas E. Hickey, Troy J. Kemp, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 516-516
Open Access | Times Cited: 5
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
Thomas E. Hickey, Troy J. Kemp, Jimmie Bullock, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
Thomas E. Hickey, Troy J. Kemp, Jimmie Bullock, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
JCI Insight (2024) Vol. 9, Iss. 8
Open Access | Times Cited: 3
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
JCI Insight (2024) Vol. 9, Iss. 8
Open Access | Times Cited: 3
Nucleocapsid and Spike Protein-Based Anti-SARS-CoV-2 Assay Performance in the Minority and Rural Coronavirus Insights Study: Characteristics of Socioeconomically Disadvantaged Populations with Health Disparities
Robert H. Christenson, Shantoy Hansel, Dora II'yasova, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 3, pp. 493-501
Closed Access | Times Cited: 1
Robert H. Christenson, Shantoy Hansel, Dora II'yasova, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 3, pp. 493-501
Closed Access | Times Cited: 1
Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2
Serge Ouoba, Aya Sugiyama, Ko Ko, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access
Serge Ouoba, Aya Sugiyama, Ko Ko, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines
Katarzyna Haynesworth, Troy J. Kemp, Sarah Loftus, et al.
mSphere (2024) Vol. 9, Iss. 11
Open Access
Katarzyna Haynesworth, Troy J. Kemp, Sarah Loftus, et al.
mSphere (2024) Vol. 9, Iss. 11
Open Access
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
Journal of Virological Methods (2024) Vol. 332, pp. 115073-115073
Open Access
Caroline L. Ashley, Malik Bloul, Sibel Alca, et al.
Journal of Virological Methods (2024) Vol. 332, pp. 115073-115073
Open Access
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Han-Sol Park, Anna Yin, Caelan Barranta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Performance Evaluation of Three Antibody Binding Assays, a Neutralizing Antibody Assay, and an Interferon-Gamma Release Assay for SARS-CoV-2 According to Vaccine Type in Vaccinated Group
Minjeong Nam, Jae Hyun, Sang‐Wook Kim, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3688-3688
Open Access | Times Cited: 1
Minjeong Nam, Jae Hyun, Sang‐Wook Kim, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3688-3688
Open Access | Times Cited: 1
Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination
Silvia Schest, Claus Langer, Yuriko Stiegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Silvia Schest, Claus Langer, Yuriko Stiegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
